{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:54:26Z","timestamp":1791222866684,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81671520"],"award-info":[{"award-number":["81671520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81571397"],"award-info":[{"award-number":["81571397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Clinical Research Program of 9th People's Hospital, Shanghai Jiao Tong University School of Medicine","award":["2016-JY04"],"award-info":[{"award-number":["2016-JY04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2850-x","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T09:25:43Z","timestamp":1534929943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"issue":"3","key":"2850_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1210\/jcem-67-3-524","volume":"67","author":"JE Hall","year":"1988","unstructured":"Hall JE, et al. Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. J Clin Endocrinol Metab. 1988;67(3):524\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"2850_CR2","first-page":"CD001750","volume":"4","author":"HG Al-Inany","year":"2016","unstructured":"Al-Inany HG, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016;4:CD001750.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2850_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560\u201379.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2850_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/humrep\/dev339","volume":"31","author":"C Blockeel","year":"2016","unstructured":"Blockeel C, et al. A fresh look at the freeze-all protocol: a SWOT analysis. Hum Reprod. 2016;31(3):491\u20137.","journal-title":"Hum Reprod"},{"issue":"1","key":"2850_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","volume":"101","author":"Y Kuang","year":"2014","unstructured":"Kuang Y, et al. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril. 2014;101(1):105\u201311.","journal-title":"Fertil Steril"},{"issue":"1","key":"2850_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62\u201370.","journal-title":"Fertil Steril"},{"issue":"1","key":"2850_CR7","first-page":"211","volume":"23","author":"N Massin","year":"2017","unstructured":"Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017;23(1):211\u201320.","journal-title":"Hum Reprod Update"},{"key":"2850_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","volume":"15","author":"Q Chen","year":"2017","unstructured":"Chen Q, et al. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reprod Biol Endocrinol. 2017;15:71.","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"2850_CR9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1210\/endo-92-5-1496","volume":"92","author":"DJ Dierschke","year":"1973","unstructured":"Dierschke DJ, et al. Blockade by progesterone of estrogen-induced LH and FSH release in the rhesus monkey. Endocrinology. 1973;92(5):1496\u2013501.","journal-title":"Endocrinology"},{"issue":"1","key":"2850_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1210\/endo.131.1.1611998","volume":"131","author":"JZ Kasa-Vubu","year":"1992","unstructured":"Kasa-Vubu JZ, et al. Progesterone blocks the estradiol-induced gonadotropin discharge in the ewe by inhibiting the surge of gonadotropin-releasing hormone. Endocrinology. 1992;131(1):208\u201312.","journal-title":"Endocrinology"},{"issue":"3","key":"2850_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2826.2005.01287.x","volume":"17","author":"TA Richter","year":"2005","unstructured":"Richter TA, et al. Progesterone can block the preovulatory gonadotropin-releasing hormone\/luteinising hormone surge in the ewe by a direct inhibitory action on oestradiol-responsive cells within the hypothalamus. J Neuroendocrinol. 2005;17(3):161\u20139.","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"2850_CR12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1365-2826.2007.01613.x","volume":"19","author":"B Attardi","year":"2007","unstructured":"Attardi B, et al. Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesteronereceptor A and B isoforms. J Neuroendocrinol. 2007;19(12):988\u20131000.","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"2850_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1210\/jcem-58-2-378","volume":"58","author":"MR Soules","year":"1984","unstructured":"Soules MR, et al. Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab. 1984;58(2):378\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2850_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/humupd\/dmi046","volume":"12","author":"R Sitruk-Ware","year":"2006","unstructured":"Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update. 2006;12(1):169\u201378.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2850_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","volume":"102","author":"DE Reichman","year":"2014","unstructured":"Reichman DE, et al. Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles. Fertil Steril. 2014;102(1):99\u2013102.","journal-title":"Fertil Steril"},{"key":"2850_CR16","doi-asserted-by":"crossref","DOI":"10.1201\/9781584889830","volume-title":"Sample size calculation in clinical research","author":"SC Chow","year":"2007","unstructured":"Chow SC, et al. Sample size calculation in clinical research. 2nd ed. New York: Taylor and Francis; 2007.","edition":"2"},{"issue":"3","key":"2850_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/JOE-15-0246","volume":"226","author":"YG Wu","year":"2015","unstructured":"Wu YG, et al. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol. 2015;226(3):167\u201380.","journal-title":"J Endocrinol"},{"issue":"3","key":"2850_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","volume":"15","author":"C Albano","year":"2000","unstructured":"Albano C, et al. Ovarian stimulation with hMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod. 2000;15(3):526\u201331.","journal-title":"Hum Reprod"},{"issue":"2","key":"2850_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1067\/S0002-9378(03)00489-7","volume":"189","author":"RT Mansour","year":"2003","unstructured":"Mansour RT, et al. The use of gonadotropin-releasing hormone antagonist in a flexible protocol: a pilot study. Am J Obstet Gynecol. 2003;189(2):444\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2850_CR20","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1093\/humrep\/dei210","volume":"20","author":"IE Messinis","year":"2005","unstructured":"Messinis IE, et al. Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment. Hum Reprod. 2005;20(11):3192\u20137.","journal-title":"Hum Reprod"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2850-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T19:16:14Z","timestamp":1566414974000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2850-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2850"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2850-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval has been granted from the Institutional Review Board of Shanghai Ninth People\u2019s Hospital. Written consent will be collected from all participants prior to enrolment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients will be informed, prior to consenting to participate in the trial, that the results of the study may be presented at academic conferences or published in peer-reviewed journals. Participants will be assured that their confidentiality will be maintained at all times and they will not be identifiable in any publications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"455"}}